Advertisement

Topics

Synpromics Ltd Company Profile

21:29 EDT 18th June 2019 | BioPortfolio

Synpromics is the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data-driven design. The company has developed PromPT®, its multi- dimensional bioinformatics database that enables product-specific promoter design and selection empowering the next generation of cell and gene based medicines and bioprocessing applications. The company operates in a diverse range of fields, including broad applications in cell and gene based medicine, biologics manufacturing and viral vector bioprocessing. Current partners include Adverum, uniQure, AGTC, GE Healthcare, Homology Medicines, Inc and Sartorius-Stedim Cellca as well as numerous undisclosed partners in the pharmaceutical sector.


News Articles [9 Associated News Articles listed on BioPortfolio]

Lonza, Synpromics Enter Biomanufacturing Partnership

Chooses Synpromics’ novel inducible promoter platform to manufacture biopharmaceuticals

Synpromics named among the top 50 fastest growing technology companies in the UK

Synpromics 12th in the Deloitte UK Technology Fast 50 Edinburgh, UK, 16th November 2018 / Sciad Newswire / Synpromics, the leader in gene control, is delighted to announce that it has been ranked 12...

uniQure incorporates novel synthetic promoter developed by Synpromics in new preclinical target

Edinburgh, UK, 5th December 2018 / Sciad Newswire / Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, developed by Synpromics, ...

Synpromics Awarded £1.9m Grant from Scottish Enterprise

Edinburgh, UK, 3rd May 2018 / Sciad Newswire / Synpromics Ltd, the leader in gene control, today announced it has been awarded a £1.9m research and development grant from Scottish Enterprise. The f...

Lonza adopts Synpromics’ inducible promoters, expands bio manufacturing platform

Lonza and Synpromics move on to the commercialization of a number of inducible promoters to expand the formerâs manufacturing offerings.

Update: Liver Gene Therapy 8 Times Stronger Than Usual

Update (06/12/2018): uniQure has incorporated Synpromics’ strong liver promoter into a preclinical gene therapy candidate for treating hemophilia A. Published on 08/10/2018 Synpromics and uniQur...

GE partner Synpromics completes financing round

Lonza chooses Synpromics’ novel inducible promoter platform to manufacture biopharmaceuticals

Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialisation of a number of inducible

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Synpromics

Synpromics is a private company focused on commercialising its proprietary technology in the emerging field of synthetic biology by developing customised synthetic promoters. The ...

Synpromics Ltd

Synpromics is the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelli...

More Information about "Synpromics Ltd" on BioPortfolio

We have published hundreds of Synpromics Ltd news stories on BioPortfolio along with dozens of Synpromics Ltd Clinical Trials and PubMed Articles about Synpromics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synpromics Ltd Companies in our database. You can also find out about relevant Synpromics Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...


Corporate Database Quicklinks



Searches Linking to this Company Record